Survival RateSurvival AnalysisPrognosisTreatment OutcomeRetrospective StudiesNeoplasm StagingDisease-Free SurvivalFollow-Up StudiesKaplan-Meier EstimateCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsCell SurvivalLung NeoplasmsTime FactorsNeoplasm Recurrence, LocalLiver NeoplasmsAdenocarcinomaProportional Hazards ModelsCisplatinLymphatic MetastasisHepatectomyCarcinoma, Non-Small-Cell LungStomach NeoplasmsMultivariate AnalysisActuarial AnalysisGraft SurvivalGastrectomySurvivalCarcinoma, Squamous CellChemotherapy, AdjuvantPancreatic NeoplasmsLymph Node ExcisionCarcinoma, HepatocellularEsophageal NeoplasmsRadiotherapy, AdjuvantBile Duct NeoplasmsPostoperative ComplicationsNeoplasm MetastasisRisk FactorsFluorouracilLiver TransplantationProspective StudiesTumor Markers, BiologicalDrug Administration ScheduleAntineoplastic AgentsNeoplasm InvasivenessMetastasectomyCholangiocarcinomaRegistriesAge FactorsEsophagectomyReoperationDeoxycytidinePneumonectomyRadiotherapy DosageRemission InductionCarcinomaCarboplatinVincristineRisk AssessmentPancreatectomyRectal NeoplasmsChemoembolization, TherapeuticColorectal NeoplasmsDoxorubicinEtoposideRecurrenceDisease ProgressionBile Ducts, IntrahepaticImmunohistochemistryCohort StudiesNeoadjuvant TherapyCarcinoma, Small CellPaclitaxelVinblastineCyclophosphamideRadiotherapy, High-EnergyLife TablesTegafurPatient SelectionAntimetabolites, AntineoplasticBreast NeoplasmsJapanSarcomaChi-Square DistributionPredictive Value of TestsBrain NeoplasmsDose FractionationGallbladder NeoplasmsPalliative CarePancreaticoduodenectomySalvage TherapyCarcinoma, Pancreatic DuctalChemoradiotherapyIncidenceBile Ducts, ExtrahepaticTaxoidsMitomycinBone NeoplasmsCarcinoma, Large Cell